Table 3.
BMR/RMR in spinal cord injury literature
| Author, year | Group(s) | n | Sex | Age (years) | 
LOI | AIS | TSI/range (years) | 
BMR/RMR (kcal/d) | 
|||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mean | SD | Mean | SD | Mean | SD | ||||||
| Aksnes et al., 1993 | Group A-meal | 6 | M | 27 | 2 | C6-C7 | Frankel A | 5 | 2 | 1321*,† | |
| Group B-water | 3 | M | 28 | 3 | C6-C7 | Frankel A | 4 | 1 | 1218*,† | ||
| Alexander et al., 1995 | Para-PI | 14 | M | 53 | 3 | Para | 20 | 3 | 1891 | 97* | |
| Para-no PI | 24 | M | 50 | 3 | Para | C/I | 22 | 3 | 1780 | 62* | |
| Aquilani et al., 2001 | All | 10 | M | 42 | 19 | Para | A | ≥ 0·2 | 1469 | 217* | |
| Barco et al., 2014 | All | 11 | M | 32† | C1-C7 | C/I | Acute | 1943**,† | |||
| Bauman et al., 2004 | Twin with SCI | 13 | M/F | 38† | C5-L2 | C/I | 15 | 9 | 1387 | 268** | |
| Bauman et al., 2011 | Testosterone Replacement | 11 | M | 43 | 6 | Para/tetra | C/I | 13 | 10 | 1328 | 262* | 
| Control | 11 | M | 35 | 9 | Para/tetra | C/I | 12 | 9 | 1319 | 112* | |
| Bauman et al., 2015 | Testosterone Treatment | 13 | M | 44 | 6 | Para/tetra | A-C | 15 | 10 | 1283 | 246* | 
| Control | 11 | M | 35 | 9 | Para/tetra | A-C | 12 | 9 | 1341 | 105* | |
| Broad et al., 2020 | Wheelchair rugby athletes | 14 | M | 31 | 6 | Para/tetra | I | 1735 | 257* | ||
| Buccholz et al., 2003 | Para | 28 | M/F | 34 | 9 | Para | C/I | 11 | 10 | 1465 | 288* | 
| Controls | 34 | 29 | 8 | 1677 | 233* | ||||||
| Chun et al., 2017 | All | 50 | M/F | 42 | 11 | Para/tetra | A, B | 12 | 7 | 1284 | 139** | 
| Para | 23 | M/F | 42 | 12 | Para | A, B | 11 | 7 | 1250 | 147** | |
| Tetra | 27 | M/F | 42 | 9 | Tetra | A, B | 13 | 8 | 1317 | 124** | |
| Collins et al., 2010 | Tetra | 32 | M/F | 53 | 14 | C5-C8 | A-D | 11 | 12 | 1411 | 315* | 
| Para | 34 | M/F | 52 | 12 | T1-L4 | A-D | 16 | 14 | 1433 | 233* | |
| Cox et al., 1985 | All | 45 | M/F | 30† | Para/tetra | 0·18 | 0·04 | 1324**,† | |||
| Farkas et al., 2019 | Tetra | 28 | M/F | 43 | 11 | C4-C8 | A, B | 16 | 11 | 1517 | 398** | 
| Para | 13 | M/F | 46 | 10 | T2-L1 | A, B | 13 | 12 | 1224 | 390** | |
| Farkas et al., 2020 | Mid-para | 6 | M/F | 31 | 11 | T6–T8 | A, B | 5 | 6 | 1491 | 241** | 
| Low-para | 5 | M | 39 | 11 | T10-L1 | A, B | 10 | 6 | 1693 | 329** | |
| Control | 5 | M/F | 29 | 12 | 1647 | 233** | |||||
| Farkas et al., 2021 | Para | 11 | M/F | 35 | 11 | T5-L1 | A, B | 7 | 6 | 1583 | 289** | 
| Controls | 6 | M/F | 29 | 12 | 1647 | 233** | |||||
| Gorgey et al., 2010 | All | 10 | M/F | 33 | 7 | C6-T11 | A, B | 11 | 7 | 1256 | 231* | 
| Gorgey et al., 2011 | All | 2 | M | 53† | C4/5, T11 | D | 0·33 | 2 | 1227* | ||
| Gorgey et al., 2012 | Exercise + diet | 5 | M | 36 | 9 | C5-T10 | A, B | 16 | 9 | 1363 | 132* | 
| Diet | 4 | M | 33 | 10 | T4-T11 | A, B | 8 | 10 | 1793 | 397* | |
| Gorgey et al., 2015 | All | 16 | M | 38 | 9 | C5-T10 | A, B | 1494 | 34** | ||
| Tetra | 6 | M | 39 | 9 | C5-C7 | A, B | 1411 | 10** | |||
| Para | 10 | M | 38 | 8 | T3–10 | A, B | 1526 | 34** | |||
| Gorgey et al., 2016 | Exercise | 6 | M | 41 | 7 | C5-T10 | A, B | 13 | 9 | 1470 | 173** | 
| Control | 5 | M | 35 | 8 | C5-T10 | A, B | 5 | 4 | 1147 | 403** | |
| Gorgey et al., 2018 | Male | 8 | 38 | 9 | 1421 | 503** | |||||
| Female | 8 | 39 | 13 | 1367 | 396** | ||||||
| Gorgey et al., 2019 | Testosterone + exercise | 11 | M | 37 | 12 | C5-T11 | A, B | 10 | 9 | 1443 | 231* | 
| Testosterone only | 11 | M | 35 | 8 | C6-T11 | A, B | 7 | 6 | 1519 | 331* | |
| Gorgey & Gater, 2011 | All | 32 | M | 36 | 9 | C5-T11 | A, B | 1431 | 345* | ||
| Tetra | 11 | M | C5-C7 | A, B | 1259 | 204* | |||||
| Para | 25 | M | T4-T11 | A, B | 1483 | 365* | |||||
| Hayes et al., 2002 | All | 11 | M/F | 36 | 8 | Para/tetra | > 3 | 1390 | 245* | ||
| Holmlund et al, 2018 | Tetra-male | 19 | M | 41 | 15 | C5–C8 | A, B | ≥ 0 | 1195 | 207* | |
| Tetra-female | 7 | F | 42 | 12 | C5–C8 | A, B | ≥ 0 | 959 | 140* | ||
| Para-male | 28 | M | 45 | 12 | T7–T12 | A, B | ≥ 0 | 1286 | 223* | ||
| Para-female | 10 | F | 39 | 11 | T7–T12 | A, B | ≥ 0 | 1030 | 206* | ||
| Kearns et al., 1992 | All | 10 | M/F | 32 | 19 | C4-T10 | Frankel A | 0·2† | 1523 | 109* | |
| Kolpek et al., 1989 | All | 7 | M/F | 34 | 5 | C2-T3 | 0–0·05 | 1760 | 288* | ||
| Lee et al., 1985 | Hypometabolic | 6 | M | 44 | 15 | C/I | 16 | 9 | 1588 | 209* | |
| Normometabolic | 5 | M | 41 | 5 | C/I | 19 | 14 | 1757 | 283* | ||
| Hypermetabolic | 6 | M | 48 | 16 | C/I | 19 | 12 | 1786 | 255* | ||
| Liu et al., 1996 | Tetra-PI | 16 | M | 40 | 3 | Tetra | 10 | 2 | 1775 | 296* | |
| Tetra-no PI | 16 | M | 40 | 2 | Tetra | 15 | 3 | 1538 | 264* | ||
| Controls | 16 | M | 43 | 3 | N/A | 1847 | 268* | ||||
| Monroe et al., 1998 | SCI | 10 | M | 36 | 8 | C6-L3 | Frankel A | 9 | 2 | 1756 | 64* | 
| Controls | 59 | M | 32 | 7 | 2212 | 317* | |||||
| Nightingale et al., 2017 | All | 33 | 44 | 9 | 1481 | 32* | |||||
| Nightingale & Gorgey, 2018 | All | 30 | M/F | 35 | 11 | C5-L1 | A, B | 35 | 11 | 1499 | 162** | 
| Tetra | 9 | 1467 | 178** | ||||||||
| Para | 21 | 1497 | 148** | ||||||||
| Pelly et al., 2017 | All | 7 | M | 31 | 7 | T3-L5 | C/I | 10–15 | 1538 | 139* | |
| Perret & Stoffel-Kurt, 2011 | Acute | 12 | M/F | 28 | 7 | C4-T10 | A, B | 0·4 | 0·3 | 1414 | 327* | 
| Chronic | 12 | M/F | 29 | 7 | C5-T12 | A, B | 5 | 2 | 1304 | 232* | |
| Rodriguez et al., 1997 | All | 12 | M/F | 32† | Para/Tetra | C/I | < 1 | 2519 | 693* | ||
| Sedlock & Laventure, 1990 | All | 4 | M | 28 | 2 | T4-L1 | 7 | 3 | 1530 | 330* | |
| Shea et al., 2018 | All | 25 | M/F | 44† | C4-C8 | C/I | 18† | 1414**,† (M)/1104**,† (F) | |||
| Spungen et al., 1993 | All | 12 | M | 42 | 3 | Para | 10 | 2 | 1854 | 70* | |
| Sumrell et al., 2018 | All | 22 | M | 36 | 10 | C5-T11 | A, B | 8 | 8 | 1137 | 280** | 
| Para | 14 | M | 35 | 9 | T4-T11 | A, B | 8 | 9 | 1216 | 278** | |
| Tetra | 8 | M | 37 | 12 | C5-C7 | A, B | 8 | 7 | 1022 | 240** | |
| Tanhoffer et al., 2012 | All | 14 | M/F | 40 | 13 | C4-T12 | A, C | 10 | 8 | 1432 | 228* | 
| Tanhoffer et al., 2014 | Sedentary group | 8 | M | 39 | 12 | C6-T12 | A, C | 90 | 6 | 1244 | 304* | 
| Exercise group | 8 | M | 40 | 15 | C6-T12 | A, C | 90 | 6 | 1200 | 234* | |
| Yilmaz et al., 2007 | AIS A | 22 | M | 32 | 11 | Tetra/para | A | 3† | 1433 | 488* | |
| AIS B | 8 | M | 33 | 11 | Tetra/para | B | 3† | 1170 | 394* | ||
| Tetra | 11 | M | 29 | 10 | Tetra | C | 3† | 1129 | 300* | ||
| Para | 19 | M | 34 | 10 | Para | C | 3† | 1499 | 508* | ||
| Yilmaz et al., 2007 | ≥ T6 | 13 | M | 29 | 9 | Tetra/para | A, B | 3 | 3 | 1407 | 586* | 
| ≤ T7 | 7 | M | 37 | 14 | Tetra/para | A, B | 3 | 3 | 1504 | 204* | |
LOI, level of injury; AIS, American Spinal Injury Association Impairment Scale; TSI, time since injury; Para, paraplegia; PI, pressure injuries; C, complete; I, incomplete; Tetra, tetraplegia. Blank spaces indicate data were not provided in the study; data are presented as mean ± standard deviation.
RMR/resting energy expenditure was measured.
Standard deviation not provided.
BMR was measured.